Lu Yan Pharmaceuticals: Net profit in the first quarter of 2026 was 67.9365 million yuan, a year-on-year decrease of 4.75%.

Egret Pharmaceutical announced that its operating revenue in the first quarter of 2026 was 5.351 billion yuan, an increase of 3.43% year-on-year. Net profit was 679.365 million yuan, a decrease of 4.75% year-on-year.